Literature DB >> 8772658

Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.

M Ichise1, J R Ballinger, H Golan, D Vines, A Luong, S Tsai, H F Kung.   

Abstract

UNLABELLED: Iodine-123-iodobenzofuran (IBF) is a potent dopamine D2 receptor ligand suited for quantitative receptor studies. The purpose of this study was to evaluate three noninvasive methods of estimating the receptor parameter k3/k4 in humans with IBF-SPECT.
METHODS: Scans were acquired every 5 min for 180 min using a triple-headed SPECT system following a bolus injection of IBF (296 +/- 37 MBq) in 14 normal volunteers. k3/k4 was estimated by the peak equilibrium ratio (RPE) method and two proposed methods: a variation of the graphic method that derives the ratio of ligand distribution volumes (RV) and area ratio (RA) method, in which the ratio is calculated from the areas under the specific binding and nondisplaceable activity curves.
RESULTS: The mean RPE, RV and RA were 2.74 +/- 0.40, 3.06 +/- 0.42 and 2.26 +/- 0.28, respectively. Both RPE and RA underestimated RV. The relationship between RPE or RA and RV was linear (p < or = 10(-5), RA showed higher correlation (r = 0.94) with RV than did RPE (r = 0.90). Simulations based on a tracer kinetic model showed that RV, unlike RPE or RA, is affected by neither regional cerebral blood flow (rCBF) nor peripheral clearance rate (CR) of IBF. All three measures showed a significant decline with increasing age (r = 0.54-0.58, p < 0.05).
CONCLUSION: RV is preferred because it provides a theoretically valid estimate of k3/k4, independently of rCBF or CR. Alternatively, RA might be preferred to RPE because the former is simpler than the latter to implement yet the former provides a measure that equally well correlates with k3/k4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772658

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  33 in total

1.  Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET.

Authors:  Masahiro Fujita; Andrea Varrone; Kyeong Min Kim; Hiroshi Watabe; Sami S Zoghbi; Nicholas Seneca; Dnyanesh Tipre; John P Seibyl; Robert B Innis; Hidehiro Iida
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

2.  Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.

Authors:  Jean-Dominique Gallezot; David Weinzimmer; Nabeel Nabulsi; Shu-Fei Lin; Krista Fowles; Christine Sandiego; Timothy J McCarthy; R Paul Maguire; Richard E Carson; Yu-Shin Ding
Journal:  Neuroimage       Date:  2010-09-30       Impact factor: 6.556

Review 3.  Brain single-photon emission CT physics principles.

Authors:  R Accorsi
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

4.  Noninvasive blood-free full quantification of positron emission tomography radioligand binding.

Authors:  Francesca Zanderigo; R Todd Ogden; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-05       Impact factor: 6.200

5.  Reference region approaches in PET: a comparative study on multiple radioligands.

Authors:  Francesca Zanderigo; R Todd Ogden; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-20       Impact factor: 6.200

Review 6.  Recent advances in parametric neuroreceptor mapping with dynamic PET: basic concepts and graphical analyses.

Authors:  Seongho Seo; Su Jin Kim; Dong Soo Lee; Jae Sung Lee
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

7.  Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves.

Authors:  M Reimold; W Mueller-Schauenburg; G A Becker; G Reischl; B M Dohmen; R Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

8.  Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study.

Authors:  Jee In Kang; Hae-Jeong Park; Se Joo Kim; Kyung Ran Kim; Su Young Lee; Eun Lee; Suk Kyoon An; Jun Soo Kwon; Jong Doo Lee
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

9.  Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans.

Authors:  Jean-Dominique Gallezot; Nabeel Nabulsi; Alexander Neumeister; Beata Planeta-Wilson; Wendol A Williams; Tarun Singhal; Sunhee Kim; R Paul Maguire; Timothy McCarthy; J James Frost; Yiyun Huang; Yu-Shin Ding; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

10.  5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Dana L Tudorascu; Elizabeth O Ahlers; Maxim S Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  Neuroimage       Date:  2013-03-26       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.